Carlsberg A/S
Carlsberg A/S (CABHF) Financial Performance & Income Statement Overview
View comprehensive annual and quarterly summaries for Carlsberg A/S (CABHF), featuring income statements, balance sheets, and cash flow data.
Carlsberg A/S (CABHF) Income Statement & Financial Overview
View the income breakdown for Carlsberg A/S CABHF across both annual and quarterly reports.
| Metric | Q4 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|
| Revenue | $36.21B | $19.38B | $19.38B | $5.30B |
| Cost of Revenue | $19.73B | $10.41B | $10.41B | $2.94B |
| Gross Profit | $16.48B | $8.97B | $8.97B | $2.36B |
| Gross Profit Ratio | $0.46 | $0.46 | $0.46 | $0.45 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $11.72B | $5.96B | $5.96B | $1.71B |
| Operating Expenses | $11.72B | $5.80B | $5.80B | $1.72B |
| Total Costs & Expenses | -$31.45B | $16.21B | $16.21B | $4.66B |
| Interest Income | $184.00M | $224.00M | $0.00 | $34.79M |
| Interest Expense | $791.00M | $689.00M | $0.00 | $91.63M |
| Depreciation & Amortization | $2.28B | $1.010B | $1.010B | $313.36M |
| EBITDA | $7.08B | $4.03B | $4.03B | $961.41M |
| EBITDA Ratio | $0.20 | $0.21 | $0.21 | $0.18 |
| Operating Income | $4.76B | $3.17B | $3.17B | $643.46M |
| Operating Income Ratio | $0.13 | $0.16 | $0.16 | $0.12 |
| Other Income/Expenses (Net) | -$754.00M | -$344.50M | -$344.50M | -$86.30M |
| Income Before Tax | $4.004B | $2.82B | $2.82B | $557.16M |
| Income Before Tax Ratio | $0.11 | $0.15 | $0.15 | $0.11 |
| Income Tax Expense | $801.00M | $599.50M | $599.50M | $95.77M |
| Net Income | $3.12B | $1.87B | $1.87B | -$6.55B |
| Net Income Ratio | $0.09 | $0.10 | $0.10 | -$1.24 |
| EPS | $23.61 | $13.80 | $13.80 | -$48.14 |
| Diluted EPS | $23.61 | $13.80 | $13.80 | -$48.14 |
| Weighted Avg Shares Outstanding | $132.08M | $135.40M | $135.40M | $136.17M |
| Weighted Avg Shares Outstanding (Diluted) | $132.08M | $135.40M | $135.40M | $136.17M |
The company's financials show resilient growth, with revenue advancing from $5.30B in Q4 2023 to $36.21B in Q4 2024. Gross profit remained healthy with margins at 46% in Q4 2024 compared to 45% in Q4 2023. Operating income hit $4.76B last quarter, sustaining a consistent 13% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $7.08B. Net income rose to $3.12B, while earnings per share reached $23.61. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan